Results 241 to 250 of about 864,032 (301)

Improving PARP inhibitor efficacy in bladder cancer without genetic BRCAness by combination with PLX51107

Molecular Oncology, EarlyView.
Clinical trials on PARP inhibitors in urothelial carcinoma (UC) showed limited efficacy and a lack of predictive biomarkers. We propose SLFN5, SLFN11, and OAS1 as UC‐specific response predictors. We suggest Talazoparib as the better PARP inhibitor for UC than Olaparib.
Jutta Schmitz, Anna L. Bartkowiak, Michael Rose, Nora Kolks, Patrick Petzsch, Vandana Solanki, Anne Stoffel, Bianca Faßbender, Leandra Lepping, Julka Volkamer, Karl Köhrer, Marc Seifert, Tokameh Mahmoudi, Tahlita C. M. Zuiverloon, Günter Niegisch, Michèle J. Hoffmann   +15 more
wiley   +1 more source

Reforming pharmacy education in Japan: insights from the 2022 model core curriculum in a global context. [PDF]

J Pharm Policy Pract
Takeda Mamiya K.
europepmc   +1 more source

Enhancing secondary school students' science process skills through guided inquiry-based laboratory activities in biology. [PDF]

PLoS One
Chengere AM, Bono BD, Zinabu SA, Jilo KW.   +3 more
europepmc   +1 more source

Aligning early childhood science teaching beliefs, practices, and children's learning outcomes: the impact of a professional development program. [PDF]

Front Psychol
Chen S, Sermeno R, Hodge KN, Geesa RL, Song HS, Izci B, Froh Z, Murphy S.   +7 more
europepmc   +1 more source

Developing Doctoral Research Skills for Workplace Inquiry

, 2016
openaire   +1 more source

Markers of Excellence: Professional Development Opportunities in an Organic Chemistry CURE. [PDF]

J Chem Educ
Boyd EA, Andersen CI, Walker JP.
europepmc   +1 more source